Incidence of aspirin resistance in the patient group of a university hospital in Korea

Korean Journal of Laboratory Medicine

Volumn 28, Issue 4, 2008, Pages 251-257

  Lee, Young Kyung ^a   Kim, Han Sung ^a   Park, Ji Young ^a   Kang, Hee Jung ^a  

^a Hallym University   (South Korea)

Author keywords

Aspirin resistance; Platelet reactivity; VerifyNow aspirin assay

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; KOREA; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; UNIVERSITY HOSPITAL;

AGED; ASPIRIN; DRUG RESISTANCE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; KOREA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS;

EID: 58149329039     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.4.251     Document Type: Article

References (24)

1. Grotemeyer KH. Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thromb Res 1991;63:587-93.
2. Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-5. (Pubitemid 32721947)
3. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5. (Pubitemid 36315537)
4. Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 2002;108:37-42. (Pubitemid 36197660)
5. Wang JC, Aucoin-Barry D, Manuelian D, Monobouquette R, Reisman M, Gray W, et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol 2003; 92:1492-4. (Pubitemid 37532584)
6. Mirkhel A, Peyster E, Sundeen J, Greene L, Michelson AD, Hasan A, et al. Frequency of aspirin resistance in a community hospital. Am J Cardiol 2006;98:577-9. (Pubitemid 44233448)
7. Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R. Comparison of a rapid platelet function assay-Verify Now Aspirin-with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res 2007;120:485-8. (Pubitemid 47094907)
8. Fontana P, Reber G, de Moerloose P. Assessing aspirin responsiveness using the Verify Now Aspirin assay. Thromb Res 2008;121: 581-2. (Pubitemid 351174263)
9. McGlasson DL and Fritsma GA. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis 2008;19:120-3. (Pubitemid 351252989)
10. Cattaneo M. Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 2007;28:1673-5. (Pubitemid 47227105)
11. Harrison P and Keeling D. Clinical tests of platelet function. In: Michelson AD, ed. Platelets. 2nd ed. California: Academic Press, 2007:445-74.
12. Bruno A, McConnel JP, Cohen SN, Tietjen GE, Wallis RA, Goreliek PB, et al. Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. Stroke 2004;35:727-30. (Pubitemid 38280849)
13. Harrison P, Segal H, Silver L, Syed A, Cuthbertson FC, Rothwell PM. Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 2008;19:119-24. (Pubitemid 351302375)
14. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-8. (Pubitemid 47227104)
15. Malinin A, Spergling M, Muhlestein B, Steinhubl S, Serebruany V. Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 2004;15:295-301. (Pubitemid 38757056)
16. Dichiara J, Bliden KP, Tantry US, Chaganti SK, Kreutz RP, Gesheff TB, et al. Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Platelets 2007;18:414-23. (Pubitemid 47347051)
17. Alberts MJ, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004;35:175-8. (Pubitemid 38057615)
18. George JN and Shattil SJ. Acquired disorders of platelet function. In: Hoffman R, Benz Jr EJ, et al. eds. Hematology: Basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:2172-86.
19. Lee PY, Chen WH, Ng W, Cheng X, Kwok JY, Tse HF, et al. Lowdose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005;118:723-7. (Pubitemid 40897657)
20. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33. (Pubitemid 43005160)
21. Cambria-Kiely JA and Gandhi PJ. Possible mechanisms of aspirin resistance. J Thromb Thrombolysis 2002;13:49-56. (Pubitemid 34624815)
22. Santos MT, Valles J, Aznar J, Marcus AJ, Broekman MJ, Safier LB. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation 1997;95:63-8. (Pubitemid 27029944)
23. Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, et al. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Am Heart J 2008;155:654-60.
24. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156-61. (Pubitemid 40185776)